GPhA Announces 2015 Board of Directors

PRESS RELEASE

(MIAMI, FL and WASHINGTON, DC, February 9, 2014) — The Generic Pharmaceutical Association (GPhA) today announced the election of its 2015 Executive Committee and Board of Directors.

Craig Wheeler, President and CEO, Momenta Pharmaceuticals, was re-elected as GPhA Board Chairman.

“The generic drug industry is growing and is stronger than ever,” said Wheeler. “GPhA members play a critical role in our nation’s health system — providing safe, effective, more affordable generic drugs for millions of people. I am extremely excited to continue to chair GPhA, seize the exciting opportunities ahead and usher in a new era of affordable medicine, particularly as we come closer to the day when the first biosimilars become available in the United States.”

Generic medicines have saved the U.S. system $1.46 trillion over the past decade and $239 billion in 2013 alone, according to the 2014 Generic Drug Savings in the U.S. report, conducted by IMS Institute for Healthcare Informatics on behalf of GPhA.

“GPhA is at the forefront of efforts to preserve the access to and savings on healthcare which our industry brings to bear at home and abroad,” said Ralph G. Neas, President and CEO, GPhA. “GPhA looks forward to partnering with industry, FDA, Congress and participants at all levels of the supply chain in order to preserve the intent of the landmark Hatch-Waxman law, meet Generic Drug User Fee Amendments goals, and encourage policies that ensure timely access to more affordable generic and biosimilar treatment options.”

The 2015-2016 GPhA Board of Directors:

Debra Barrett (Teva Americas)

Doug Boothe (Perrigo Company)

Chuck Caprariello (Ranbaxy, Inc.)

John Ducker (Fresenius-Kabi)

Jeff Glazer (Heritage Pharmaceuticals)

Peter Goldschmidt (Sandoz US)

Marcy Macdonald (Impax Laboratories)

Marcie McClintic Coates (Mylan Inc.)

Paul McGarty (Lupin Pharmaceuticals)

Chirag Patel (Amneal Pharmaceuticals)

Tony Pera (Par Pharmaceuticals)

Julie Reed (Hospira Inc.)

Joseph Renner (Zydus Pharmaceuticals, Inc.)

Jeff Watson (Apotex Corporation)

Craig Wheeler (Momenta Pharmaceuticals)

About GPhA

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 86 percent of the prescriptions dispensed in the U.S. but consume just 27 percent of the total drug spending. Additional information is available at gphaonline.org. Follow us on twitter: @gpha.